Références
Lee HH, Song IH, Friedrich M, Gauliard A, Detert J, Röwert J, et al. Cutaneous side-effects in patients with rheumatic diseases during application of tumour necrosis factor-alpha antagonists. Br J Dermatol 2007;156:486–491.
Collamer AN, guerrero KT, Henning JS, Battafarano DF. Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: a literature review and potential mechanisms of action. Arthritis Rheum 2008;59:996–1001.
Ko JM, Gottlieb AB, Kerbleski JF. Induction and exacerbation of psoriasis with tNF-blockade therapy: a review and analysis of 127 cases. J Dermatolog treat 2009;20:100–108.
Rahier JF, Buche S, Peyrin-Biroulet L, Bouhnik Y, Duclos B, Louis E, et al. severe skin lesions cause patients with inflammatory bowel disease to discontinue anti-tumor necrosis factor therapy. Clin Gastroenterol Hepatol 2010;8:1048–1055.
Kerbleski JF, gottlieb AB. Dermatological complications and safety of anti-tNF treatments. gut 2009;58:1033–1039.
Williams VL, Cohen PR. alpha antagonist-induced lupus-like syndrome: report and review of the literature with implications for treatment with alternative alpha antagonists. Int J Dermatol 2011;50:619–625.
Viguier M, Richette P, Bachelez H, Wendling D, Aubin F. Paradoxical adverse effects of anti-tNF-alpha treatment: onset or exacerbation of cutaneous disorders. Expert Rev Clin Immunol 2009;5:421–431.
Lourari S, Prey S, Livideanu C, Jamard B, Lamant L, Cantagrel A, et al. Cutaneous t-cell lymphoma following treatment of rheumatoid arthritis with tumour necrosis factor-alpha blocking agents: two cases. J Eur Acad Dermatol Venereol 2009;23:967–968.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Faure, P., Rahier, J.F. & Buche, S. Lésions cutanées induites par les anti-TNF-alpha. Acta Endosc 41, 292–295 (2011). https://doi.org/10.1007/s10190-011-0195-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10190-011-0195-3